UNSPSC 51284010: Meclocycline

This classification denotes a tetracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23Q8M2HE6S. European Medicines Agency schedules Meclocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08677MIG. Meclocycline generally arises in the molecular formula C22H21CLN2O8. The term MECLOCYCLINE is an International Non-Proprietary Name or INN. MECLOCYCLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule meclocycline under HS 29413000 and SITC 54133. As of Q4 2014, MECLOCYCLINE remains the US FDA Preferred Term for this commodity. Meclocycline bears US NLM identifiers UMLS ID C0065841 and NCI Concept Code C61825. SMILES: CLC1C2C(=C)C3C(O)C4C(O)(C(=O)C3=C(O)C2C(O)CC1)C(=O)/C(=C(\O)N)C(=O)C4N(C)C.

UNSPSC 51284010 Meclocycline is a Commodity code representing pharmaceutical active ingredients and finished-form medications; state and local opportunities under this code show recent purchases of antibiotic tablets, naloxone products, and drug deactivation systems for public health and community health initiatives. The issuing bodies are primarily state departments of public health and county health authorities procuring through cooperative purchasing agreements (such as MMCAP Infuse consortiums) or direct competitive bids. State and local governments use this code to source medications and pharmaceutical products for emergency preparedness, disease prevention, and opioid-response programs, with quantities ranging from hundreds of units annually to multi-million-dollar warehouse supply contracts.

Recent activity spans Florida and Illinois. The Illinois Department of Public Health awarded a $2,999,999.11 three-year piggyback pharmaceutical warehouse contract to Chartwell Rx LLC in August 2026 (IFB process; contract number 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse consortium. Seminole County, Florida issued an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract included two-year initial term with one-year renewal option and compliance with E-Verify and drug-free workplace requirements. Both opportunities use electronic bidding portals and award contracts on a lowest-priced, responsive-and-responsible basis.